1. Home
  2. Labeler Index
  3. Ascend Laboratories, Llc
  4. 67877-882
  5. Product Images: Rivaroxaban

Product Images Rivaroxaban

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. riv-cart-u-1 - riv cart u 1
  2. riv-fig-ifu1-u-b - riv fig ifu1 u b
  3. riv-fig-ifu10-u - riv fig ifu10 u
  4. riv-fig-ifu11-u - riv fig ifu11 u
  5. riv-fig-ifu12-u - riv fig ifu12 u
  6. riv-fig-ifu13-u - riv fig ifu13 u
  7. riv-fig-ifu14-u-b - riv fig ifu14 u b
  8. riv-fig-ifu15-u - riv fig ifu15 u
  9. riv-fig-ifu16-u - riv fig ifu16 u
  10. riv-fig-ifu17-u-b - riv fig ifu17 u b
  11. riv-fig-ifu18-u-b - riv fig ifu18 u b
  12. riv-fig-ifu19-u-b - riv fig ifu19 u b
  13. riv-fig-ifu2-u-b - riv fig ifu2 u b
  14. riv-fig-ifu20-1u - riv fig ifu20 1u
  15. riv-fig-ifu21-u-b - riv fig ifu21 u b
  16. riv-fig-ifu22-u-b - riv fig ifu22 u b
  17. riv-fig-ifu23-u-b - riv fig ifu23 u b
  18. riv-fig-ifu24-u - riv fig ifu24 u
  19. riv-fig-ifu25-u-b - riv fig ifu25 u b
  20. riv-fig-ifu26-u - riv fig ifu26 u
  21. riv-fig-ifu27-u - riv fig ifu27 u
  22. riv-fig-ifu28-u-b - riv fig ifu28 u b
  23. riv-fig-ifu29-u - riv fig ifu29 u
  24. riv-fig-ifu3-u-b - riv fig ifu3 u b
  25. riv-fig-ifu4-u - riv fig ifu4 u
  26. riv-fig-ifu5-u - riv fig ifu5 u
  27. riv-fig-ifu6-u - riv fig ifu6 u
  28. riv-fig-ifu7-u - riv fig ifu7 u
  29. riv-fig-ifu8-u - riv fig ifu8 u
  30. riv-fig-ifu9-u - riv fig ifu9 u
  31. riv-fig2-u - riv fig2 u
  32. riv-fig3-u - riv fig3 u
  33. riva-str-u - riv str u

Product Label Images

The following 33 images provide visual information about the product associated with Rivaroxaban NDC 67877-882 by Ascend Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

riv-cart-u-1 - riv cart u 1

riv-cart-u-1 - riv cart u 1

This is a description of a medication called Rivaroxaban for Oral Suspension, with a recommended dosage of 1 mg/m when reconstituted. The text provides instructions on how pharmacists should reconstitute the medication before dispensing and emphasizes counseling caregivers on proper use. It also highlights the importance of storing the medication correctly, administering the dose by an adult caregiver, and providing a Medication Guide to each patient. The text includes details on the contents of the package, storage instructions, and a website for additional instructions for use. Additionally, it mentions manufacturing and distribution information for the product.*

riv-fig-ifu1-u-b - riv fig ifu1 u b

riv-fig-ifu1-u-b - riv fig ifu1 u b

riv-fig-ifu10-u - riv fig ifu10 u

riv-fig-ifu10-u - riv fig ifu10 u

This is a useful tip for using a bottle of liquid medication. It emphasizes the importance of avoiding shaking the bottle too fast to prevent foaming, as this can result in an incorrect dosage being given. It is important to handle the bottle carefully to ensure accurate medication administration.*

riv-fig-ifu11-u - riv fig ifu11 u

riv-fig-ifu11-u - riv fig ifu11 u

riv-fig-ifu12-u - riv fig ifu12 u

riv-fig-ifu12-u - riv fig ifu12 u

riv-fig-ifu13-u - riv fig ifu13 u

riv-fig-ifu13-u - riv fig ifu13 u

Use the oral dosing syringe provided with rivaroxaban for oral suspension to ensure accurate dosing.*

riv-fig-ifu14-u-b - riv fig ifu14 u b

riv-fig-ifu14-u-b - riv fig ifu14 u b

riv-fig-ifu15-u - riv fig ifu15 u

riv-fig-ifu15-u - riv fig ifu15 u

This text provides dose measures for different quantities of liquid medication in milliliters. For example, 7.5mL is a mix of 5mL and 25mL, 10mL is a combination of 5mL and 5mL, 15mL consists of 5mL, 5mL, and 5mL, and 20mL is made up of 5mL, 5mL, 5mL, and 5mL.*

riv-fig-ifu16-u - riv fig ifu16 u

riv-fig-ifu16-u - riv fig ifu16 u

riv-fig-ifu17-u-b - riv fig ifu17 u b

riv-fig-ifu17-u-b - riv fig ifu17 u b

riv-fig-ifu18-u-b - riv fig ifu18 u b

riv-fig-ifu18-u-b - riv fig ifu18 u b

riv-fig-ifu19-u-b - riv fig ifu19 u b

riv-fig-ifu19-u-b - riv fig ifu19 u b

riv-fig-ifu2-u-b - riv fig ifu2 u b

riv-fig-ifu2-u-b - riv fig ifu2 u b

riv-fig-ifu20-1u - riv fig ifu20 1u

riv-fig-ifu20-1u - riv fig ifu20 1u

This message serves as a reminder to ensure you have an adequate supply of medication to complete the full dose prescribed. Avoid taking partial doses as it may not be effective or safe.*

riv-fig-ifu21-u-b - riv fig ifu21 u b

riv-fig-ifu21-u-b - riv fig ifu21 u b

riv-fig-ifu22-u-b - riv fig ifu22 u b

riv-fig-ifu22-u-b - riv fig ifu22 u b

riv-fig-ifu23-u-b - riv fig ifu23 u b

riv-fig-ifu23-u-b - riv fig ifu23 u b

riv-fig-ifu24-u - riv fig ifu24 u

riv-fig-ifu24-u - riv fig ifu24 u

This text "Step 5: Give the dose" indicates that in a set of instructions or process, the fifth step involves administering a certain quantity of medication or substance. This step is crucial in providing the intended treatment or effect as prescribed.*

riv-fig-ifu25-u-b - riv fig ifu25 u b

riv-fig-ifu25-u-b - riv fig ifu25 u b

riv-fig-ifu26-u - riv fig ifu26 u

riv-fig-ifu26-u - riv fig ifu26 u

This text provides instructions on how to administer a dose of medication using a syringe. It advises that if the dose is greater than 5 mL, the same syringe may need to be used multiple times, requiring the individual to repeat steps 4 and 5 to complete the required dose.*

riv-fig-ifu27-u - riv fig ifu27 u

riv-fig-ifu27-u - riv fig ifu27 u

This text instructs the reader to rinse and store an item, likely as part of a set of steps in a process or procedure.*

riv-fig-ifu28-u-b - riv fig ifu28 u b

riv-fig-ifu28-u-b - riv fig ifu28 u b

riv-fig-ifu29-u - riv fig ifu29 u

riv-fig-ifu29-u - riv fig ifu29 u

This is a safety warning advising against placing the oral dosing syringe in the dishwasher for cleaning. It is important to follow these instructions to avoid damage to the syringe or potential contamination of medication.*

riv-fig-ifu3-u-b - riv fig ifu3 u b

riv-fig-ifu3-u-b - riv fig ifu3 u b

riv-fig-ifu4-u - riv fig ifu4 u

riv-fig-ifu4-u - riv fig ifu4 u

riv-fig-ifu5-u - riv fig ifu5 u

riv-fig-ifu5-u - riv fig ifu5 u

riv-fig-ifu6-u - riv fig ifu6 u

riv-fig-ifu6-u - riv fig ifu6 u

This appears to be a simple instruction related to food safety. The text advises to check the "Discard after" date, implying that the product should be discarded after that specified date to ensure freshness and safety.*

riv-fig-ifu7-u - riv fig ifu7 u

riv-fig-ifu7-u - riv fig ifu7 u

riv-fig-ifu8-u - riv fig ifu8 u

riv-fig-ifu8-u - riv fig ifu8 u

riv-fig-ifu9-u - riv fig ifu9 u

riv-fig-ifu9-u - riv fig ifu9 u

riv-fig2-u - riv fig2 u

riv-fig2-u - riv fig2 u

This text provides information regarding the Population Description PK Fold Change and 90% CI for different conditions such as End-Stage Renal Disease, Renal Impairment, Age groups, Body Weight categories, and Hepatic Impairment. It includes comparisons such as severe vs. normal renal impairment, different age groups, body weight categories, and levels of hepatic impairment, along with the associated fold change and 90% confidence intervals. The data appears to be related to the pharmacokinetics of rivaroxaban in specific patient populations, including those with end-stage renal disease and different degrees of renal and hepatic impairments.*

riv-fig3-u - riv fig3 u

riv-fig3-u - riv fig3 u

riva-str-u - riv str u

riva-str-u - riv str u

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.